BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1693417)

  • 1. [Drug treatment of Graves' ophthalmopathy].
    Prummel MF; Wiersinga WM
    Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
    Hegedüs L
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency analysis of using tailored individual doses of radioiodine and fine tuning using a low-dose antithyroid drug in the treatment of Graves' disease.
    Liu CJ; Dong YY; Wang YW; Wang KH; Zeng QY
    Nucl Med Commun; 2011 Mar; 32(3):227-32. PubMed ID: 21191313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
    Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' disease in children.
    Hung W
    Curr Ther Endocrinol Metab; 1997; 6():77-81. PubMed ID: 9174708
    [No Abstract]   [Full Text] [Related]  

  • 11. Graves' disease.
    Walter MA; Christ-Crain M; Muller B
    N Engl J Med; 2008 Sep; 359(13):1407; author reply 1409. PubMed ID: 18815405
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithyroid drugs.
    Nebesio TD; Eugster EA
    N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15926207
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F; Martino E; Bartalena L
    J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of antithyroid drugs on the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre.
    Sabri O; Zimny M; Buell U
    Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):160-1. PubMed ID: 11807618
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
    Eschmann SM; Thelen MH; Dittmann H; Bares R
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):222-6. PubMed ID: 16804795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduced antithyroid agents as a result of radioiodine therapy?].
    Maka D; Schicha H; Körber C; Schneider P; Reiners C
    Nuklearmedizin; 2000; 39(2):N25-6. PubMed ID: 10768174
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V; Voth E; Moka D; Schicha H
    Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-thyroid drug treatment before radioiodine in patients with Graves' disease: soother or menace?
    Perros P
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):1-2. PubMed ID: 10931073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.